Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Nihon Jinzo Gakkai Shi|November 25, 2003
[Quadritherapy with cyclosporine for membranous lupus nephropathy]Hiroshi Matsumoto, Tomonari Okada, Yume Nagaoka, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 10, 2009
Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.Nihon Jinzo Gakkai Shi|September 5, 2008
[Day-by-day variability of home blood pressure in patients with chronic kidney disease]Tomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.Internal Medicine (Tokyo, Japan)|July 16, 2005
Insulin resistance contributes to obesity-related proteinuriaHiroshi Matsumoto, Toshiyuki Nakao, Tomonari Okada, et al.Nephrology (Carlton, Vic.)|November 17, 2010
Clinical evaluation of chronic nephrotoxicity of long-term cyclosporine A treatment in adult patients with steroid-dependent nephrotic syndromeTomonari Okada, Hiroshi Matsumoto, Yume Nagaoka, et al.Internal Medicine (Tokyo, Japan)|January 8, 2011
Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.Internal Medicine (Tokyo, Japan)|June 19, 2007
Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.Internal Medicine (Tokyo, Japan)|October 8, 2004
Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndromeHiroshi Matsumoto, Toshiyuki Nakao, Tomonari Okada, et al.Nephrology (Carlton, Vic.)|December 4, 2010
Benefits of first-half intensive haemodiafiltration for the removal of uraemic solutesYume Nagaoka, Hiroshi Matsumoto, Tomonari Okada, et al.Pageof 2